Results 141 to 150 of about 133,417 (336)

Total neoadjuvant therapy in rectal cancer: The FOREST protocol, a patient‐centered approach that clusters two cohorts with different outcomes

open access: yesInternational Journal of Cancer, EarlyView.
What's New? Treatment strategies for rectal cancer are increasingly focused on organ preservation and tailored therapy. Total neoadjuvant therapy (TNT), which integrates radiotherapy and systemic chemotherapy prior to surgery, is especially promising in this regard.
Hector Guadalajara   +14 more
wiley   +1 more source

Chemoradiotherapy response in recurrent rectal cancer. [PDF]

open access: yes, 2014
Bhangu, A   +5 more
core   +1 more source

The prognostic value of cell‐free DNA dynamics during chemoradiotherapy in squamous cell carcinomas of the anus

open access: yesInternational Journal of Cancer, EarlyView.
What's New? Chemoradiotherapy is the standard treatment for squamous cell carcinoma of the anus (SCCA). Toxicities linked to chemoradiotherapy, however, can negatively impact the quality of life, and biomarkers to distinguish which patients will benefit from treatment are lacking.
Anne Vittrup Jakobsen   +4 more
wiley   +1 more source

Adjuvant nivolumab after chemoradiotherapy and resection for patients with esophageal cancer: A real‐world matched comparison of overall survival

open access: yesInternational Journal of Cancer, EarlyView.
What's New? Patients with esophageal or gastroesophageal junction (GEJ) cancer with residual disease after treatment with neoadjuvant chemoradiotherapy (nCRT) and resection frequently experience poor survival. Improvements in outcome, however, may be possible using adjuvant treatment with nivolumab.
Rob H. A. Verhoeven   +9 more
wiley   +1 more source

Surgical approaches to adenocarcinoma of the gastroesophageal junction: the Siewert II conundrum. [PDF]

open access: yes, 2017
BACKGROUND: The Siewert classification system for gastroesophageal junction adenocarcinoma has provided morphological and topographical information to help guide surgical decision-making.
Berger, Adam C.   +4 more
core   +1 more source

Oncologic outcome and recurrence patterns of clinical stage IB and IIA cervical cancer: A large retrospective analysis of a tertiary reference center

open access: yesInternational Journal of Gynecology &Obstetrics, EarlyView.
Abstract Objective To evaluate the outcomes and recurrence patterns and define the parameters that can help to predict high‐risk patients among our 20‐year clinical early‐stage IB–IIA cervical cancer patients treated with traditional (non‐nerve sparing) radical surgery.
Osman Aşıcıoğlu   +4 more
wiley   +1 more source

Can neoadjuvant chemoradiotherapy affect exfoliated cancer cells in colorectal cancer?

open access: yesBMC Surgery
Background To prevent local recurrence caused by exfoliated cancer cells caught in the suture line, intraoperative rectal washout during surgery can be performed to eliminate exfoliated cancer cells.
Ji Ha Lim   +7 more
doaj   +1 more source

Improved functional oral intake and exercise training attenuate decline in aerobic capacity following chemoradiotherapy in patients with esophageal cancer

open access: yesJournal of Rehabilitation Medicine
Purpose: To investigate the impact of chemoradiotherapy on the physical fitness of patients with oesophageal cancer, and the clinical factors influencing it.
Shu-Chun Huang   +7 more
doaj   +1 more source

The Value of [18F]FDG PET/CT for Differentiating Neoplastic From Benign Thrombus

open access: yesiRADIOLOGY, EarlyView.
Schematic overview of vascular thrombus in cancer patients and the diagnostic utility of [18F]FDG PET/CT for differentiating neoplastic from benign thrombus. Left: Illustrative diagram depicting tumor‐induced vascular thrombus formation in malignant tumor patients (created using FigDraw [by figdraw. com] with authorization; IDs: AORTA66266).
Xiaofeng Dou   +8 more
wiley   +1 more source

Preventive Effect of Rebamipide Gargle on Chemoradiotherpy-Induced Oral Mucositis in Patients with Oral Cancer: a Pilot Study

open access: yeseJournal of Oral Maxillofacial Research, 2011
Objectives: To assess the efficacy and safety of rebamipide in preventing chemoradiotherapy-induced oral mucositis in patients with oral cancer.Material and Methods: Patients with oral cancer treated with chemoradiotherapy (daily radiotherapy plus ...
Takashi Yasuda   +6 more
doaj  

Home - About - Disclaimer - Privacy